Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07633223Phase 4Completed
Phase 4, randomised, open-label trial in asthma (2 arms), sponsored by Beni Suef University. Primary endpoints: Amount of aerosols at 1 week, Lung Bioavailability at 1 week and 1 more. Started Sep 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07633223.